News

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...
Engerix-B can interact with hepatitis B antibody tests. These tests show whether antibodies such as the hepatitis B surface antigen (HBsAg) are present. Specifically, detecting HBsAg helps doctors ...
These are people who do not have hepatitis B but fail to develop enough antibodies after vaccination to prevent infection. It is estimated that between 5% and 10% of people vaccinated for ...
The study, reported Dec. 1 in JAMA, showed that hepatitis B vaccine with a cytosine phosphoguanine adjuvant, known as HepB-CpG, (trade name Heplisav-B) induced protective levels of antibodies in ...
They are considered protected if they have a hepatitis B surface antigen antibody (anti-HBs) titer of ≥10 mIU/mL after completing a full vaccination series. This study compared the effectiveness ...
According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...
They are considered protected if they have a hepatitis B surface antigen antibody (anti-HBs) titer of ≥10 mIU/mL after completing a full vaccination series. This study compared the effectiveness ...
Pregnant women with hepatitis B can be given antibodies or antiviral medication to prevent hepatitis B transmission to their babies. Most people who get hepatitis B as adults will naturally clear the ...
Hepatitis A and B are the most common vaccine-preventable ... with nearly all subjects developing hepatitis A antibodies (anti-HAV) within 2 weeks. [3] However, a second dose of vaccine, given ...
This large-scale exploratory study demonstrated that the prevalence of HDV antibody positivity was ... patients were hepatitis B e antigen-positive. The mean (standard deviation) HBsAg level ...